Collegium Pharmaceutical (COLL) Assets Average: 2016-2025
Historic Assets Average for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $1.6 billion.
- Collegium Pharmaceutical's Assets Average rose 19.02% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 19.02%. This contributed to the annual value of $1.4 billion for FY2024, which is 21.12% up from last year.
- According to the latest figures from Q3 2025, Collegium Pharmaceutical's Assets Average is $1.6 billion, which was down 0.75% from $1.6 billion recorded in Q2 2025.
- Collegium Pharmaceutical's Assets Average's 5-year high stood at $1.6 billion during Q4 2024, with a 5-year trough of $645.0 million in Q1 2021.
- Moreover, its 3-year median value for Assets Average was $1.2 billion (2023), whereas its average is $1.3 billion.
- Its Assets Average has fluctuated over the past 5 years, first surged by 83.24% in 2022, then declined by 10.73% in 2024.
- Quarterly analysis of 5 years shows Collegium Pharmaceutical's Assets Average stood at $716.9 million in 2021, then surged by 65.64% to $1.2 billion in 2022, then decreased by 2.28% to $1.2 billion in 2023, then skyrocketed by 42.13% to $1.6 billion in 2024, then rose by 19.02% to $1.6 billion in 2025.
- Its Assets Average was $1.6 billion in Q3 2025, compared to $1.6 billion in Q2 2025 and $1.6 billion in Q1 2025.